Posts by suzy
U-NEURON Biomedical Presented UA002 Ahead of BioJapan, Impressing International Stakeholders
Regenerative medicine company U-NEURON Biomedical presented its proprietary amniotic fluid stem cell drug candidate UA002 during the Link-J roadshow session prior to BioJapan on October 7. BioJapan is Asia's flagship medical exhibition, serving as an ideal platform for regenerative medicine. The Link-J Global Life Science Session brought together participants from over 10 countries across the Americas, Japan, Europe, Asia, and Australia. Led by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) of the Ministry of Economic Affairs, the delegation introduced top-performing Taiwanese biomedical companies during the international roadshow.
GTP-Grade Cell banking: Exclusive AFSC Isolation & 20-Year Cryopreservation
In our high-specification GTP laboratory certified by the Taiwan FDA (TFDA), we provide exclusive amniotic fluid stem cell isolation and purification services for expectant mothers, along with up to 20 years of liquid nitrogen cryopreservation, seamlessly connecting to diverse personalized regenerative medicine and product applications.
Amniotic Fluid Stem Cell Exosomes (AFSC-EXO): Rich in Diverse Bioactivity
Accordingtoa 2025 study from the University of Oxford, amniotic fluid exosomes contain a richer and more diverse miRNA profile than umbilical cord stem cell exosomes, demonstrating superior bioactivity and efficacy in regulating tissue regeneration, anti-inflammation, and anti-fibrosis.
Amniotic Fluid Stem Cells (AFSC): The Youngest & High-Potential Stem Cells Globally
Holder of exclusive global patents for isolation and purification. As the youngest stem cells, Amniotic Fluid Stem Cells (AFSCs) possess safety, high differentiation, and other key characteristics. This scientific discovery was selected by TIME Magazine as one of the Top 10 Medical Breakthroughs. U-NEURON continues to advance its R&D and clinical applications.